Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,491 | -31,315 | -15,693 | -62,839 | -47,204 |
| Depreciation Amortization | 692 | 478 | 243 | 861 | 629 |
| Accounts payable and accrued liabilities | 983 | 580 | -227 | 1,384 | 133 |
| Other Working Capital | 575 | 500 | -1,202 | 3,447 | 3,672 |
| Other Operating Activity | 6,084 | 4,215 | 2,612 | 8,348 | 7,241 |
| Operating Cash Flow | $-37,157 | $-25,542 | $-14,267 | $-48,799 | $-35,529 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -375 | -279 | -127 | -1,134 | -995 |
| Purchase Of Investment | -20,016 | -20,016 | -20,016 | -36,129 | -36,130 |
| Sale Of Investment | 33,500 | 18,500 | 5,500 | 70,000 | 53,500 |
| Other Investing Activity | 0 | 0 | 0 | 264 | 264 |
| Investing Cash Flow | $13,109 | $-1,795 | $-14,643 | $33,001 | $16,639 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 561 | 493 | 493 | 45,865 | 45,841 |
| Other Financing Activity | -27 | -27 | -27 | -76 | -75 |
| Financing Cash Flow | $534 | $466 | $466 | $45,789 | $45,766 |
| Beginning Cash Position | 56,058 | 56,058 | 56,058 | 26,067 | 26,067 |
| End Cash Position | 32,544 | 29,187 | 27,614 | 56,058 | 52,943 |
| Net Cash Flow | $-23,514 | $-26,871 | $-28,444 | $29,991 | $26,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,157 | -25,542 | -14,267 | -48,799 | -35,529 |
| Capital Expenditure | -375 | -279 | -127 | -1,134 | -995 |
| Free Cash Flow | -37,532 | -25,821 | -14,394 | -49,933 | -36,524 |